149 related articles for article (PubMed ID: 34648230)
1. Structure-Activity Relationship Studies of Hydantoin-Cored Ligands for Smoothened Receptor.
Liu Y; Zhou F; Ding K; Xue D; Zhu Z; Li C; Li F; Xu Y; Xu F; Le Z; Zhao S; Tao H
ChemistryOpen; 2021 Oct; 10(10):1028-1032. PubMed ID: 34648230
[TBL] [Abstract][Full Text] [Related]
2. Colocalization Strategy Unveils an Underside Binding Site in the Transmembrane Domain of Smoothened Receptor.
Zhou F; Ding K; Zhou Y; Liu Y; Liu X; Zhao F; Wu Y; Zhang X; Tan Q; Xu F; Tan W; Xiao Y; Zhao S; Tao H
J Med Chem; 2019 Nov; 62(21):9983-9989. PubMed ID: 31408335
[TBL] [Abstract][Full Text] [Related]
3. Deciphering structural stability and binding mechanisms of potential antagonists with smoothened protein.
Sinha N; Chowdhury S; Sarkar RR
J Biomol Struct Dyn; 2018 Aug; 36(11):2917-2937. PubMed ID: 28849750
[TBL] [Abstract][Full Text] [Related]
4. A NanoBRET-Based Binding Assay for Smoothened Allows Real-time Analysis of Ligand Binding and Distinction of Two Binding Sites for BODIPY-cyclopamine.
Kozielewicz P; Bowin CF; Turku A; Schulte G
Mol Pharmacol; 2020 Jan; 97(1):23-34. PubMed ID: 31707356
[TBL] [Abstract][Full Text] [Related]
5. Hydantoin-substituted 4,6-dichloroindole-2-carboxylic acids as ligands with high affinity for the glycine binding site of the NMDA receptor.
Jansen M; Potschka H; Brandt C; Löscher W; Dannhardt G
J Med Chem; 2003 Jan; 46(1):64-73. PubMed ID: 12502360
[TBL] [Abstract][Full Text] [Related]
6. Molecular Modelling of Berberine Derivatives as Inhibitors of Human Smoothened Receptor and Hedgehog Signalling Pathway Using a Newly Developed Algorithm on Anti-Cancer Drugs.
Kaboli PJ; Bazrafkan M; Ismail P; Ling KH
Recent Pat Anticancer Drug Discov; 2017 Nov; 12(4):384-400. PubMed ID: 28969581
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis of drug resistance in smoothened receptor: An in silico study of protein resistivity and specificity.
Sinha N; Chowdhury S; Sarkar RR
Proteins; 2020 Mar; 88(3):514-526. PubMed ID: 31589795
[TBL] [Abstract][Full Text] [Related]
8. NanoBRET and NanoBiT/BRET-Based Ligand Binding Assays Permit Quantitative Assessment of Small Molecule Ligand Binding to Smoothened.
Kozielewicz P; Schulte G
Methods Mol Biol; 2022; 2374():195-204. PubMed ID: 34562254
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and pharmacological evaluation of Tic-hydantoin derivatives as selective sigma1 ligands. Part 1.
Charton J; Cazenave Gassiot A; Girault-Mizzi S; Debreu-Fontaine MA; Melnyk P; Sergheraert C
Bioorg Med Chem Lett; 2005 Nov; 15(21):4833-7. PubMed ID: 16140011
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and pharmacological evaluation of Tic-hydantoin derivatives as selective sigma1 ligands. Part 2.
Cazenave Gassiot A; Charton J; Girault-Mizzi S; Gilleron P; Debreu-Fontaine MA; Sergheraert C; Melnyk P
Bioorg Med Chem Lett; 2005 Nov; 15(21):4828-32. PubMed ID: 16140009
[TBL] [Abstract][Full Text] [Related]
11. Elucidation of Distinct Modular Assemblies of Smoothened Receptor by Bitopic Ligand Measurement.
Zhao F; Wu Y; Zhou F; Xue D; Zhao S; Lu W; Liu X; Hu T; Qiu Y; Li R; Gu T; Xu Y; Xu F; Zhong G; Jiang Z; Zhao S; Tao H
J Med Chem; 2021 Sep; 64(18):13830-13840. PubMed ID: 34492176
[TBL] [Abstract][Full Text] [Related]
12. Structural dynamics of Smoothened (SMO) in the ciliary membrane and its interaction with membrane lipids.
Kumari S; Mitra A; Bulusu G
Biochim Biophys Acta Biomembr; 2022 Aug; 1864(8):183946. PubMed ID: 35483421
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs.
Wang C; Wu H; Evron T; Vardy E; Han GW; Huang XP; Hufeisen SJ; Mangano TJ; Urban DJ; Katritch V; Cherezov V; Caron MG; Roth BL; Stevens RC
Nat Commun; 2014 Jul; 5():4355. PubMed ID: 25008467
[TBL] [Abstract][Full Text] [Related]
14. Hedgehog pathway modulation by multiple lipid binding sites on the smoothened effector of signal response.
Myers BR; Sever N; Chong YC; Kim J; Belani JD; Rychnovsky S; Bazan JF; Beachy PA
Dev Cell; 2013 Aug; 26(4):346-57. PubMed ID: 23954590
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of a multi-domain human smoothened receptor in complex with a super stabilizing ligand.
Zhang X; Zhao F; Wu Y; Yang J; Han GW; Zhao S; Ishchenko A; Ye L; Lin X; Ding K; Dharmarajan V; Griffin PR; Gati C; Nelson G; Hunter MS; Hanson MA; Cherezov V; Stevens RC; Tan W; Tao H; Xu F
Nat Commun; 2017 May; 8():15383. PubMed ID: 28513578
[TBL] [Abstract][Full Text] [Related]
16. Molecular modeling study on the dynamical structural features of human smoothened receptor and binding mechanism of antagonist LY2940680 by metadynamics simulation and free energy calculation.
Bai Q; Shen Y; Jin N; Liu H; Yao X
Biochim Biophys Acta; 2014 Jul; 1840(7):2128-38. PubMed ID: 24637074
[TBL] [Abstract][Full Text] [Related]
17. Analysis of vismodegib resistance in D473G and W535L mutants of SMO receptor and design of novel drug derivatives using molecular dynamics simulations.
Liao S; Floyd C; Verratti N; Leung L; Wu C
Life Sci; 2020 Mar; 244():117302. PubMed ID: 31953165
[TBL] [Abstract][Full Text] [Related]
18. MRT-92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor.
Hoch L; Faure H; Roudaut H; Schoenfelder A; Mann A; Girard N; Bihannic L; Ayrault O; Petricci E; Taddei M; Rognan D; Ruat M
FASEB J; 2015 May; 29(5):1817-29. PubMed ID: 25636740
[TBL] [Abstract][Full Text] [Related]
19. Triazoles bind the C-terminal domain of SMO: Illustration by docking and molecular dynamics simulations the binding between SMO and triazoles.
Liu M; Liang G; Zheng H; Zheng N; Ge H; Liu W
Life Sci; 2019 Jan; 217():222-228. PubMed ID: 30543826
[TBL] [Abstract][Full Text] [Related]
20. Oxysterol binding to the extracellular domain of Smoothened in Hedgehog signaling.
Nedelcu D; Liu J; Xu Y; Jao C; Salic A
Nat Chem Biol; 2013 Sep; 9(9):557-64. PubMed ID: 23831757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
